Last Name



This is a "connection" page, showing publications co-authored by Susan Abdel-Rahman and Stephani Stancil.

Connection Strength
  1. Stancil SL, Mirzayev F, Abdel-Rahman SM. Profiling Pretomanid as a Therapeutic Option for TB Infection: Evidence to Date. Drug Des Devel Ther. 2021; 15:2815-2830.
    View in: PubMed
    Score: 0.973
  2. Stancil SL, Berrios C, Abdel-Rahman S. Adolescent perceptions of pharmacogenetic testing. Pharmacogenomics. 2021 04; 22(6):335-343.
    View in: PubMed
    Score: 0.959
  3. Stancil SL, Adelman W, Dietz A, Abdel-Rahman S. Naltrexone Reduces Binge Eating and Purging in Adolescents in an Eating Disorder Program. J Child Adolesc Psychopharmacol. 2019 11; 29(9):721-724.
    View in: PubMed
    Score: 0.850
  4. Stancil SL, Pearce RE, Tyndale RF, Kearns GL, Vyhlidal CA, Leeder JS, Abdel-Rahman S. Evaluating metronidazole as a novel, safe CYP2A6 phenotyping probe in healthy adults. Br J Clin Pharmacol. 2019 05; 85(5):960-969.
    View in: PubMed
    Score: 0.830
  5. Stancil SL, Abdel-Rahman S, Wagner J. Developmental Considerations for the Use of Naltrexone in Children and Adolescents. J Pediatr Pharmacol Ther. 2021; 26(7):675-695.
    View in: PubMed
    Score: 0.247
  6. Stancil SL, van Haandel L, Abdel-Rahman S, Pearce RE. Development of a UPLC-MS/MS method for quantitation of metronidazole and 2-hydroxy metronidazole in human plasma and its application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Aug 15; 1092:272-278.
    View in: PubMed
    Score: 0.197
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.